Q1 2019 Recordati Industria Chimica e Farmaceutica SpA Earnings & 2019-2021 Business Plan Call Transcript
I'm going to start as it's 10:31. Welcome. Thank you for coming to participate to the presentation of the global strategy, development strategy of Recordati and the objectives for the 2019 and '21 plan. You obviously already have insight in advance, insights on these numbers because they were released in the press release forming the Board of Directors yesterday. But obviously, the plan today is to give you more color and information on what lies behind this plan, so strategy-wise and the financials and sales functions-wise.
So for those of you who don't know Recordati because I know there are a few of you that don't know the company, I will go to Slide 4, please, Marianne, to give a quick profile of Recordati and what Recordati is today. Recordati is an Italian-originated pharmaceutical company. The company, obviously we closed 2018 with EUR 1.3 billion worth of sales. And we have 4,142 employees across the world. The company has 2 main business units, one is the specialty and primary care business unit,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
